AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 17, 2022
50715_rns_2022-06-17_dcd999a2-ed5c-4bd1-abbc-ea172701acdf.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
17 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Descriptionof relevantsecurities | Nature of dealings | Purchase/ Sale | Totalnumber ofsharesinvolved | Total amountpaid / received | Highest (H)prices paid/ received | Lowest (L)prices paid/ received |
|---|---|---|---|---|---|---|---|---|
| CICC FinancialTrading Limited | 16 June2022 | Other typesof securities(e.g. equityswaps) | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing | Sale | 10,000 | $263,494.0500 | $26.3494 | $26.3494 |
Public Disclosure Form
==> picture [71 x 43] intentionally omitted <==
| Ordinaryshares | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginating client-driven dealing | Purchase | 10,000 | $263,000.0000 | $26.3000 | $26.3000 |
|---|
End
Note:
CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.
More from CStone Pharmaceuticals
Regulatory Filings
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 1
AGM Information
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
Jun 1
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27